Evidence map›Paper›PMID 39897440›Full record

ArticleCardiology research2025

First Transcatheter Valve-in-Valve Implantation With Myval Octacor Into a Failed Biological Prosthetic Aortic Valve in Serbia.

Valentina Balint Jovanovic, Mihajlo Farkic, Darko Boljevic, Milovan Bojic, Matija Furtula, Dragan Topic, Milan Dobric, Alfonso Ielasi, Vladimir Zobenica, Ida Subotic and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valentina Balint JovanovicDedinje Cardiovascular Institute, Belgrade, Serbia.
Mihajlo FarkicDedinje Cardiovascular Institute, Belgrade, Serbia.
Darko BoljevicDedinje Cardiovascular Institute, Belgrade, Serbia.
Milovan BojicDedinje Cardiovascular Institute, Belgrade, Serbia.
Matija FurtulaDedinje Cardiovascular Institute, Belgrade, Serbia.
Dragan TopicDedinje Cardiovascular Institute, Belgrade, Serbia.
Milan DobricDedinje Cardiovascular Institute, Belgrade, Serbia.
Alfonso IelasiU.O. Cardiologia Ospedaliera, IRCCS Ospedale Galeazzi-Sant-Ambrogio, Milan, Italy.
Vladimir ZobenicaDedinje Cardiovascular Institute, Belgrade, Serbia.
Ida SuboticDedinje Cardiovascular Institute, Belgrade, Serbia.
Aleksandra NikolicDedinje Cardiovascular Institute, Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natural progression of bioprosthetic valve degeneration over time requires further interventions for those experiencing symptomatic prosthesis dysfunction. Transcatheter aortic valve replacement (TAVR) emerges as a promising therapeutic option to alleviate symptoms in such patients. The valve-in-valve (ViV) technique eliminates the necessity for repetitive open-heart surgical procedures, offering particular advantages for individuals with higher surgical risks. In this report, we describe the case of a 78-year-old female patient presenting with severe symptomatic aortic restenosis of a biological aortic valve implanted 5 years prior. Given the patient's high surgical risk, a transcatheter ViV implantation was chosen as the treatment approach. Utilizing a balloon-expandable valve, the intervention resulted in the successful implantation of a functional TAVR, resulting in symptom relief and enabling a fast discharge from the hospital.

Indexed as

Aortic restenosisBalloon-expandable valveFailed surgical bioprosthesesMyval OctacorTranscatheter aortic valve replacementTranscatheter heart valveValve-in-valve

Identifiers

PMID39897440
PMCPMC11779679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.